Theraclion specialises in high-tech medical equipment using high-intensity focused ultrasound (HIFU). We offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumours.
Theraclion a French company created in 2004, is a spin-off of Edap-Technomed, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures and markets a medical device, Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. Treatment of varicose veins of the leg is undergoing clinical trials.
Theraclion is ISO 13 485 certified and has received the CE mark for these first 2 pathologies.
Located in Malakoff, near Paris, Theraclion has a team of 24 people, 53% of whom are dedicated to R & D and clinical trials.
Theraclion is now the only company in the world to offer a completely non-invasive treatment for breast adenofibromas and benign thyroid nodules and is the only company specializing in superficial targets. This solution presents today an alternative to surgery and minimally invasive techniques.
Theraclion is listed on Alternext Paris Eligible for PEA-PME Mnemonic ALTHE – ISIN code: FR0010120402.